GTR Home > Tests > Dent Disease (Type 1, Type 2)


Test name


Dent Disease (Type 1, Type 2)

Purpose of the test


Contribute to generalizable knowledge



3 conditions tested. Click Condition tab for more information.


Molecular Genetics
CSequence analysis of the entire coding region
Bi-directional Sanger Sequence Analysis
  • Applied Biosystems 3730 capillary sequencing instrument

Summary of what is tested

2 genes and variants. Click Methodology tab for more information.


Description of study


The purpose of this study is to screen patients with clinical suspicion of Dent Disease (elevated low molecular weight proteins with nephrocalcinosis, kidney stones or hypercalciuria), and in first and/or second degree relatives of probands with confirmed CLCN5 or ORCL1 variants when necessary for segregation analysis


Person responsible for the studyHelpJohn C. Lieske, MD, Lab Director
Study contactHelpJohn C. Lieske, MD, Lab Director,
Co-investigatorHelpDawn Milliner, MD, Lab Director

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center